证券日报网讯2月4日，蜂助手（301382）在互动平台回答投资者提问时表示，为保证信息披露的公平 性，公司将在定期报告中披露对应时点的股东人数。 ...

（文章来源：证券日报） 证券日报网讯 2月3日，蜂助手在互动平台回答投资者提问时表示，公司紧跟鸿蒙原生应用的发展节 奏，持续迭代升级云终端核心技术并加大相关研发投入，通过云端算力调度与端云协同技术能力，实现 多设备高效协同，同时依托云端算力赋能，有效提升老旧设备的运行体验，实现旧设备的功能焕新。公 司云终端技术有望进一步挖掘各类场景化需求，为公司带来新的增量市场空间。 ...

证券日报网讯 2月3日，蜂助手在互动平台回答投资者提问时表示，公司依托云终端技术与算力运营能 力，在运营商提供的网络基础上，凭借端到端的全栈技术构建核心竞争力，可提供终端虚拟化、云 OS、算力资源智慧调度引擎、端云协同引擎、SDK等技术解决方案，充分保障网络数据传输与网络时 延等。公司相关核心技术均有专利布局与技术储备，具体技术指标请以公开信息为准。 （文章来源：证券日报） ...

Core Insights - The domestic medical beauty industry is undergoing a structural transformation in 2025, shifting from a "seller's market" to a "buyer's market" due to an increase in the supply of upstream products [1] - The approval of 52 new Class III medical device registrations in 2025 indicates a significant change in the supply-demand relationship within the industry [1] - Upstream manufacturers are compelled to adjust their competitive strategies, focusing on technological innovation, product iteration speed, and commercialization capabilities [1][4] Upstream Manufacturers - The competition among upstream manufacturers is intensifying as the medical beauty market continues to expand and diversify, with the industry size surpassing 300 billion yuan [3] - The light medical beauty market is expected to grow at a compound annual growth rate of over 20% in the next five years, becoming the mainstream segment [3] - Hyaluronic acid, botulinum toxin, collagen, and regenerative materials are projected to dominate the injection materials market in 2024, with respective market shares of 36%, 29%, 19%, and 16% [3] Product Supply Expansion - In 2025, 25 new Class III medical device registrations for hyaluronic acid products were approved, alongside approvals for collagen products, youth needles, and new materials like agarose and calcium phosphate [4] - Manufacturers are shifting from a "follow the trend" model to focusing on product innovation and expanding new indications, particularly in women's health-related aesthetics [4][5] Competitive Landscape - The competition is expected to transition from merely obtaining licenses to a focus on core technology, research efficiency, and understanding end-user needs [5] - The relationship between upstream manufacturers and downstream medical beauty institutions is evolving into a mutually beneficial partnership rather than a zero-sum game [6] Downstream Institutions - The approval of 52 new Class III medical device registrations has provided downstream institutions with greater product selection and negotiating power with upstream manufacturers [6] - New Oxygen's introduction of competitively priced products has sparked controversy among upstream manufacturers, highlighting the ongoing price competition in the market [6] Market Dynamics - Public hospitals are increasingly entering the medical beauty sector, with 203 hospitals opening or establishing medical beauty departments in 2025, a 229% increase from the previous year [8] - Major internet platforms like Meituan and Tmall are leveraging their traffic advantages to enhance the medical beauty sector, intensifying market competition [8] - The future of the medical beauty industry is expected to be characterized by a diverse and competitive landscape, where trust and professional credibility are crucial for consumer acceptance [8]

本报讯 （记者李昱丞）1月28日，合觅科技品牌发布会暨产品发布会在2026年好莱客经销商峰会上顺利 举行。发布会上，合觅科技智能家居产品——智能5GCPE音箱、智能云音箱、语音助手-觅宝等一系列 AI智能家居产品公开亮相，呈现智能家居解决方案。 资料显示，广州合觅科技有限公司由蜂助手股份有限公司（以下简称"蜂助手"）、广州好莱客创意家居 股份有限公司、广东好太太科技集团股份有限公司联合投资成立。蜂助手为合资公司提供硬件集成模 组、无线宽带连接、窄带通信技术、自研垂类模型、端云协同、数字权益资源等能力及服务。 蜂助手方面表示，未来凭借公司在AI大模型融合、数字权益、物联网通信整合等领域的核心优势，将 加快落地推出各类AI智能终端，以其为万物互联的关键节点，助力各场景的AI应用落地。 （编辑 郭之宸） 蜂助手相关负责人表示，这是蜂助手全面推进"硬件+云终端+服务+场景"的AI应用一体化的重要举措。 一方面，蜂助手将成熟的无线宽带与Mesh组网能力深度适配家庭场景，叠加TPUNB超窄带通信技术的 低功耗、广覆盖特性，实现家中各类智能终端的自动组网与稳定连接，解决了市场同类产品需用户手动 逐一配对、连接稳定性不足的行 ...

Core Viewpoint - The news highlights a rare "win-win" scenario in the A-share market, where both Haixia Innovation and its associate company, Fengzhushou, report significant performance forecasts for 2025, showcasing a balance between quality equity layout and focus on core business [1] Group 1: Haixia Innovation - Haixia Innovation expects a net profit attributable to shareholders of 100 million to 150 million yuan for 2025, a staggering increase of 1660.56% to 2540.85% compared to 5.68 million yuan in the previous year [1] - The substantial profit increase is primarily driven by strategic equity reduction rather than breakthroughs in its main business, with non-recurring gains estimated at 200 million to 300 million yuan, mainly from the reduction of Fengzhushou shares [3] - Despite the profit surge, Haixia Innovation's core business faces operational pressures, with a reported revenue of 92.06 million yuan for the third quarter of 2025, a slight increase of 4.7%, but a net loss of 17.24 million yuan [4] Group 2: Fengzhushou - Fengzhushou anticipates a net profit attributable to shareholders of 142 million to 174 million yuan for 2025, with a growth rate of over 6%, and revenue expected to exceed 1.9 billion yuan [4] - The company's growth is attributed to the synergy of core business operations and ongoing cost control, with a significant revenue increase of 57.57% in the third quarter of 2025 [5] - Fengzhushou's performance aligns with the industry's growth in computing power infrastructure, with a projected 43% year-on-year increase in China's intelligent computing power scale for 2025 [6] Group 3: Market Dynamics - The interaction between Haixia Innovation and Fengzhushou illustrates a healthy capital operation model, where Haixia Innovation's equity reduction supports its core business during a challenging period, while Fengzhushou benefits from improved liquidity and stable growth [7] - The overall environment for the smart city industry is under pressure, with another company in the sector expected to report a net loss, highlighting the significance of Haixia Innovation's strategic equity reduction [7] - The capital market's healthy development requires companies to focus on their core business while optimizing resource allocation through reasonable capital operations, as demonstrated by the collaboration between Haixia Innovation and Fengzhushou [8]

Core Viewpoint - The company, Haixia Innovation, expects a significant increase in net profit for 2025, primarily due to the reduction of its holdings in the stock of Fengzhushou, which has positively impacted its financial performance [2][3]. Financial Performance - The company forecasts a net profit attributable to shareholders of between 1 billion to 1.5 billion yuan, representing a year-on-year growth of 1660.56% to 2540.85% [2][3]. - Non-recurring gains and losses are estimated to impact the financial results by approximately 200 million to 300 million yuan, mainly due to the partial divestment of Fengzhushou shares [2][3]. Stock Divestment Strategy - Haixia Innovation plans to reduce its holdings in Fengzhushou by up to 837.46 million shares, accounting for 2.93% of Fengzhushou's total share capital, through various methods including centralized bidding and block trading [3][4]. - The company acquired 25.4 million shares of Fengzhushou between 2014 and 2019, representing 19.97% of its total shares before the IPO [4]. Business Focus and Future Strategy - Despite the gains from stock divestment, the company emphasizes its commitment to focusing on its core business, particularly in the smart city sector, and aims to cultivate new growth points to enhance overall competitiveness [6]. - The company has experienced significant stock price increases, with a rise of over 100% in October 2023, indicating strong market performance [5].

Core Viewpoint - The company, Haixia Innovation, expects a significant increase in net profit attributable to shareholders in 2025, primarily due to the reduction of its holdings in the stock of Fengzhushou, which has positively impacted its financial performance [1][2]. Financial Performance - The company forecasts a net profit attributable to shareholders of between 1 billion to 1.5 billion yuan, representing a year-on-year growth of 1660.56% to 2540.85% [1][2]. - Non-recurring gains and losses are estimated to impact the financial results by approximately 200 million to 300 million yuan, mainly due to the partial divestment of Fengzhushou shares [1][2]. Stock Divestment Strategy - The company plans to reduce its holdings in Fengzhushou by up to 8.3746 million shares, accounting for 2.93% of Fengzhushou's total share capital, through various methods including centralized bidding and block trading [2][4]. - The divestment is part of a strategy to optimize asset structure and improve liquidity and efficiency, which has significantly contributed to the expected profit increase [2][4]. Business Focus - Despite the gains from Fengzhushou, the company emphasizes its commitment to its core business, focusing on the development of smart city initiatives and exploring new growth opportunities to enhance overall competitiveness and drive high-quality development [5].

| ☑ | 特定对象调研 | □分析师会议 | | --- | --- | --- | | | □媒体采访 | □业绩说明会 | | 投资者关系活 | □新闻发布会 | □路演活动 | | 动类别 | | | | | □现场参观 | | | ☑ | 其他 投资者通过线上会议方式接入 | | | | 天风证券、博时基金、恒泰证券、湖南源乘私募基金、杭州拾 | | | | 年投资、天弘基金、诺安基金、泰康資產（香港）、上海筌笠 | | | | 资产、睿亿投资、太平基金、承珞（上海）投资、中信证券、 | | | | 南京青云合益投资、招商局仁和人寿保险、北京源乐晟资产、 | | | Ten | Management、国信证券、上海方御投资、Marshall Asset | | | | Wace、泰信基金、上海侏罗纪资产、深圳前海云溪基金、循远 | | | 参与单位名称 | 资产（上海）、浙江臻远投资、中信建投基金、长城财富保险 | | | 及人员姓名 | 资产、杭州明见投资、诺德基金、深圳前海无锋基金、上海非 | | | | 马投资、同泰基金、瑞锐投资（上海）、华泰证券（上海）资 | | | | 产、卷柏科技、中国 ...

蜂助手（301382）(301382.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净利润1.42亿元 至1.74亿元，同比增长6.16%至30.09%;扣除非经常性损益后的净利润1.4亿元至1.71亿元，同比增长 6.61%至30.21%。 ...